BDTX

BDTX

USD

Black Diamond Therapeutics Inc. Common Stock

$2.375+0.025 (1.064%)

Prix en Temps Réel

Healthcare
Biotechnologie
États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché
Fondamentaux de l'Entreprise
Statistiques de Trading

Métriques de Marché

Ouverture

$2.350

Haut

$2.380

Bas

$2.300

Volume

0.56M

Fondamentaux de l'Entreprise

Capitalisation Boursière

135.0M

Industrie

Biotechnologie

Pays

United States

Statistiques de Trading

Volume Moyen

3.50M

Bourse

NMS

Devise

USD

Intervalle sur 52 Semaines

Bas $1.195Actuel $2.375Haut $6.75

Actualités Connexes

GlobeNewswire

Servier and Black Diamond Therapeutics Announce Global Licensing Agreement for BDTX-4933, A Targeted Oncology Therapy

The partnership underscores Servier's commitment to developing targeted therapies that address unmet medical needs in oncologyServier will develop and commercialize BDTX-4933, a Phase 1 asset with best-in-class potential

Voir plus
Servier and Black Diamond Therapeutics Announce Global Licensing Agreement for BDTX-4933, A Targeted Oncology Therapy
Analyst Upgrades

HC Wainwright & Co. Maintains Buy on Black Diamond Therapeutic, Raises Price Target to $12

HC Wainwright & Co. analyst Robert Burns maintains Black Diamond Therapeutic with a Buy and raises the price target from $11 to $12.

Voir plus
HC Wainwright & Co. Maintains Buy on Black Diamond Therapeutic, Raises Price Target to $12
Analyst Upgrades

Stifel Maintains Buy on Black Diamond Therapeutic, Lowers Price Target to $15

Stifel analyst Bradley Canino maintains Black Diamond Therapeutic with a Buy and lowers the price target from $16 to $15.

Voir plus
Stifel Maintains Buy on Black Diamond Therapeutic, Lowers Price Target to $15

Restez Informé

Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.